Threshold Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US8858072064
Biotechnology & Medical Research
Sales 2024 * | 12.7M 1.06B | Sales 2025 * | 1.37M 114M | Capitalization | 9.55M 796M |
---|---|---|---|---|---|
Net income 2024 * | -22M -1.83B | Net income 2025 * | -34M -2.84B | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.98 x |
P/E ratio 2024 * |
-0.45
x | P/E ratio 2025 * |
-0.37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.04% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 01/00/01 |
Jason Kim
PSD | President | 49 | 01/10/01 |
Kristen Quigley
COO | Chief Operating Officer | 53 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 01/00/01 |
Harold Selick
CHM | Chairman | 69 | 01/17/01 |
David Hoffmann
BRD | Director/Board Member | 79 | 01/17/01 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |